{"id":16052,"date":"2024-08-16T00:56:04","date_gmt":"2024-08-16T00:56:04","guid":{"rendered":"https:\/\/longevityhealthplans.com\/?p=16052"},"modified":"2024-11-19T19:40:19","modified_gmt":"2024-11-19T19:40:19","slug":"GLP-2-the-next-big-thing-in-endocrinology","status":"publish","type":"post","link":"https:\/\/longevityhealthplans.com\/es\/blog\/GLP-2-the-next-big-thing-in-endocrinology\/","title":{"rendered":"GLP-2: The Next Big Thing in Endocrinology?"},"content":{"rendered":"<p>Endocrinology, the branch of medicine focused on hormones and metabolism, has seen remarkable advancements in recent years, particularly in the treatment of Type 2 diabetes and obesity. Among the most promising developments is GLP-2, a novel medication that has the potential to revolutionize the field. With its unique dual-action mechanism and impressive clinical results, GLP-2 is being hailed as the next big thing in endocrinology. In this article, we\u2019ll explore why GLP-2 is generating so much excitement and what it could mean for the future of endocrine care.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">The Dual-Action Mechanism of GLP-2<\/h4>\n\n\n\n<p>GLP-2 is the first medication to target both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. These incretin hormones play critical roles in regulating glucose metabolism, insulin secretion, and appetite control.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>GLP-1 Agonism:<\/strong> GLP-1 receptor agonists, like semaglutide, have been a cornerstone of Type 2 diabetes treatment due to their ability to enhance insulin secretion, inhibit glucagon release, and slow gastric emptying. These effects help lower blood sugar levels and promote weight loss by reducing appetite.<\/li>\n\n\n\n<li><strong>GIP Agonism:<\/strong> GIP, another incretin hormone, has additional effects on fat metabolism and energy expenditure. By activating the GIP receptor, GLP-2 enhances insulin sensitivity and promotes the utilization of fat for energy, contributing to greater weight loss and improved glucose control.<\/li>\n<\/ul>\n\n\n\n<p>The combination of GLP-1 and GIP receptor agonism offers a more comprehensive approach to managing metabolic disorders, addressing multiple pathways involved in glucose regulation and weight management.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Clinical Success and Potential Impact<\/h4>\n\n\n\n<p>GLP-2 has demonstrated exceptional efficacy in clinical trials, particularly in the SURPASS studies, where it consistently outperformed other leading diabetes medications, including semaglutide.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Glucose Control:<\/strong> GLP-2 has shown superior results in lowering HbA1c levels, a key marker of long-term blood glucose control. In some trials, GLP-2 reduced HbA1c by up to 2.4%, setting a new benchmark for diabetes treatment.<\/li>\n\n\n\n<li><strong>Weight Loss:<\/strong> In addition to its glucose-lowering effects, GLP-2 has been remarkably effective in promoting weight loss. Patients treated with GLP-2 in clinical trials experienced weight reductions of up to 20% of their body weight\u2014a result that is comparable to bariatric surgery.<\/li>\n\n\n\n<li><strong>Cardiovascular Benefits:<\/strong> While more research is needed, early data suggest that GLP-2 may also have cardiovascular benefits, including reducing the risk of major adverse cardiovascular events in patients with Type 2 diabetes and obesity.<\/li>\n<\/ul>\n\n\n\n<p>These results have positioned GLP-2 as a potential game-changer in endocrinology, offering a new option for patients who need more aggressive treatment for metabolic disorders.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Broader Implications for Endocrine Care<\/h4>\n\n\n\n<p>The success of GLP-2 in clinical trials has broader implications for the field of endocrinology. Its dual-action mechanism represents a shift towards more comprehensive treatment strategies that address the multifaceted nature of metabolic disorders. This approach acknowledges that conditions like Type 2 diabetes and obesity are not just about blood sugar levels or weight\u2014they involve complex interactions between hormones, metabolism, and energy balance.<\/p>\n\n\n\n<p>As GLP-2 becomes more widely available, it could lead to a reevaluation of treatment protocols for metabolic disorders. Healthcare providers may begin to prioritize medications that offer multiple benefits, such as glucose control, weight loss, and cardiovascular protection, rather than focusing on a single aspect of treatment.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">The Future of Endocrinology<\/h4>\n\n\n\n<p>Looking ahead, GLP-2\u2019s success could pave the way for the development of other multifunctional medications that target different hormonal pathways involved in metabolic health. These future treatments could offer even more effective solutions for managing complex conditions like diabetes, obesity, and cardiovascular disease.<\/p>\n\n\n\n<p>GLP-2\u2019s introduction also highlights the importance of personalized medicine in endocrinology. As we gain a deeper understanding of how different hormones interact in the body, there will be more opportunities to tailor treatments to individual patient needs, improving outcomes and quality of life.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Conclusi\u00f3n<\/h4>\n\n\n\n<p>GLP-2 is poised to become the next big thing in endocrinology, offering a novel and highly effective treatment option for patients with Type 2 diabetes and obesity. Its dual-action mechanism, which targets both GLP-1 and GIP receptors, sets it apart from other medications and offers a more comprehensive approach to managing metabolic disorders. As GLP-2 becomes more widely adopted, it has the potential to transform endocrine care and improve outcomes for millions of patients worldwide.<\/p>","protected":false},"excerpt":{"rendered":"<p>Endocrinology, the branch of medicine focused on hormones and metabolism, has seen remarkable advancements in recent years, particularly in the treatment of Type 2 diabetes and obesity. Among the most promising developments is GLP-2, a novel medication that has the potential to revolutionize the field. With its unique dual-action mechanism and impressive clinical results, GLP-2 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16079,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":""},"categories":[118],"tags":[121,126,119,125,123,120],"class_list":["post-16052","post","type-post","status-publish","format-link","has-post-thumbnail","hentry","category-hrt-hormone-replacement-therapy","tag-estrogen","tag-hormonal-leveles","tag-hormones","tag-perimenopause","tag-testosterone","tag-therapy","post_format-post-format-link","pmpro-has-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GLP-2: The Next Big Thing in Endocrinology? - Longevity Health Plans<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/longevityhealthplans.com\/es\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-2: The Next Big Thing in Endocrinology? - Longevity Health Plans\" \/>\n<meta property=\"og:description\" content=\"Endocrinology, the branch of medicine focused on hormones and metabolism, has seen remarkable advancements in recent years, particularly in the treatment of Type 2 diabetes and obesity. Among the most promising developments is GLP-2, a novel medication that has the potential to revolutionize the field. With its unique dual-action mechanism and impressive clinical results, GLP-2 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/longevityhealthplans.com\/es\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/\" \/>\n<meta property=\"og:site_name\" content=\"Longevity Health Plans\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-16T00:56:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T19:40:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/08\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Dawood\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dawood\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/\"},\"author\":{\"name\":\"Dawood\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#\\\/schema\\\/person\\\/efdcc4ff54b9490c9effb7f8fded56cd\"},\"headline\":\"GLP-2: The Next Big Thing in Endocrinology?\",\"datePublished\":\"2024-08-16T00:56:04+00:00\",\"dateModified\":\"2024-11-19T19:40:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/\"},\"wordCount\":692,\"image\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png\",\"keywords\":[\"estrogen\",\"hormonal leveles\",\"hormones\",\"perimenopause\",\"testosterone\",\"therapy\"],\"articleSection\":[\"HRT | Hormone Replacement Therapy\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/\",\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/\",\"name\":\"GLP-2: The Next Big Thing in Endocrinology? - Longevity Health Plans\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png\",\"datePublished\":\"2024-08-16T00:56:04+00:00\",\"dateModified\":\"2024-11-19T19:40:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#\\\/schema\\\/person\\\/efdcc4ff54b9490c9effb7f8fded56cd\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png\",\"contentUrl\":\"https:\\\/\\\/longevityhealthplans.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/blog\\\/tirzepatide-the-next-big-thing-in-endocrinology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/longevityhealthplans.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tirzepatide: The Next Big Thing in Endocrinology?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#website\",\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/\",\"name\":\"Longevity Health Plans\",\"description\":\"Longevity Healthcare: Empowering Your Journey to Optimal Wellness\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/longevityhealthplans.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/longevityhealthplans.com\\\/#\\\/schema\\\/person\\\/efdcc4ff54b9490c9effb7f8fded56cd\",\"name\":\"Dawood\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g\",\"caption\":\"Dawood\"},\"sameAs\":[\"https:\\\/\\\/webdevoceason.com\"],\"url\":\"https:\\\/\\\/longevityhealthplans.com\\\/es\\\/blog\\\/author\\\/hormonehealthplans-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-2: The Next Big Thing in Endocrinology? - Longevity Health Plans","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/longevityhealthplans.com\/es\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/","og_locale":"es_MX","og_type":"article","og_title":"GLP-2: The Next Big Thing in Endocrinology? - Longevity Health Plans","og_description":"Endocrinology, the branch of medicine focused on hormones and metabolism, has seen remarkable advancements in recent years, particularly in the treatment of Type 2 diabetes and obesity. Among the most promising developments is GLP-2, a novel medication that has the potential to revolutionize the field. With its unique dual-action mechanism and impressive clinical results, GLP-2 [&hellip;]","og_url":"https:\/\/longevityhealthplans.com\/es\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/","og_site_name":"Longevity Health Plans","article_published_time":"2024-08-16T00:56:04+00:00","article_modified_time":"2024-11-19T19:40:19+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/08\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png","type":"image\/png"}],"author":"Dawood","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dawood","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#article","isPartOf":{"@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/"},"author":{"name":"Dawood","@id":"https:\/\/longevityhealthplans.com\/#\/schema\/person\/efdcc4ff54b9490c9effb7f8fded56cd"},"headline":"GLP-2: The Next Big Thing in Endocrinology?","datePublished":"2024-08-16T00:56:04+00:00","dateModified":"2024-11-19T19:40:19+00:00","mainEntityOfPage":{"@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/"},"wordCount":692,"image":{"@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#primaryimage"},"thumbnailUrl":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/08\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png","keywords":["estrogen","hormonal leveles","hormones","perimenopause","testosterone","therapy"],"articleSection":["HRT | Hormone Replacement Therapy"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/","url":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/","name":"GLP-2: The Next Big Thing in Endocrinology? - Longevity Health Plans","isPartOf":{"@id":"https:\/\/longevityhealthplans.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#primaryimage"},"image":{"@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#primaryimage"},"thumbnailUrl":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/08\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png","datePublished":"2024-08-16T00:56:04+00:00","dateModified":"2024-11-19T19:40:19+00:00","author":{"@id":"https:\/\/longevityhealthplans.com\/#\/schema\/person\/efdcc4ff54b9490c9effb7f8fded56cd"},"breadcrumb":{"@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#primaryimage","url":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/08\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png","contentUrl":"https:\/\/longevityhealthplans.com\/wp-content\/uploads\/2024\/08\/Tirzepatide-The-Next-Big-Thing-in-Endocrinology.png","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/longevityhealthplans.com\/blog\/tirzepatide-the-next-big-thing-in-endocrinology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/longevityhealthplans.com\/"},{"@type":"ListItem","position":2,"name":"Tirzepatide: The Next Big Thing in Endocrinology?"}]},{"@type":"WebSite","@id":"https:\/\/longevityhealthplans.com\/#website","url":"https:\/\/longevityhealthplans.com\/","name":"Longevity Health Plans","description":"Longevity Healthcare: Potenciando tu viaje hacia el bienestar \u00f3ptimo","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/longevityhealthplans.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/longevityhealthplans.com\/#\/schema\/person\/efdcc4ff54b9490c9effb7f8fded56cd","name":"Daud","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d0540b75bd5db5d4baee1b7905f34706888c2b0ef338e401909e07bc4a75b040?s=96&d=mm&r=g","caption":"Dawood"},"sameAs":["https:\/\/webdevoceason.com"],"url":"https:\/\/longevityhealthplans.com\/es\/blog\/author\/hormonehealthplans-com\/"}]}},"_links":{"self":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts\/16052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/comments?post=16052"}],"version-history":[{"count":3,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts\/16052\/revisions"}],"predecessor-version":[{"id":16374,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/posts\/16052\/revisions\/16374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/media\/16079"}],"wp:attachment":[{"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/media?parent=16052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/categories?post=16052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/longevityhealthplans.com\/es\/wp-json\/wp\/v2\/tags?post=16052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}